At Evergrowth BioHealthcare Capital, we believe the key to successful investing lies in understanding a stock’s intrinsic value—the true worth of a company based on its fundamentals, not fleeting market sentiment. For young growth biotech stocks, intrinsic value is dynamic, evolving with each milestone in their journey from lab to market. Let’s explore how this...
Coronary Artery Disease or CAD is one of the leading health challenges worldwide. This condition is estimated to impact billions globally and remains a significant burden on healthcare systems. At Evergrowth, we see this condition as something that will prevail in the upcoming years especially with the current trend in lifestyle. Poor diet, lack of...
Did you know that there are sneaky, slow-growing neuroendocrine tumors that can disrupt lives with hormone overproduction and mysterious symptoms? These are called Carcinoid tumors which affect the gut, lungs, and sometimes even the heart. These tumors might be rare, but their impact? Enormous! While the causes of these tumors are uncertain, carcinoid tumor research...
Did you know that around 30,000 people worldwide are diagnosed with mesothelioma each year? This rare but deadly cancer, mostly caused by asbestos exposure, has been a silent threat lurking in our walls, our ceilings, and even our communities. And while famous people like Steve McQueen tragically battled this disease in the past, today we’re...
Imagine a disease that not only impacts 10 million people yearly but also challenges the world with drug-resistant strains. That disease is tuberculosis (TB), and it’s a silent crisis affecting lives across all backgrounds—even stars like Nelson Mandela, who battled TB during his time in prison. Fortunately, we are now seeing biotech innovations that are...
Pulmonary hypertension – a condition that not only affects millions worldwide but also claimed the life of legendary singer Natalie Cole. Today, we explore the battle against this life-altering disease. In 2024, pulmonary hypertension is estimated to affect 1% of the global population. The condition, often marked by shortness of breath, fatigue, and chest pain,...
Imagine a world where chronic skin conditions like eczema are no longer a daily struggle, thanks to breakthrough biotechnology. In today’s video, we’re diving deep into eczema — also known as atopic dermatitis — a condition that impacts millions worldwide. Far more than just dry skin, eczema can cause intense discomfort, itching, and inflammation. Traditional...
Explore the latest innovations in lung cancer research, diagnosis, and treatment, as well as emerging market trends in the industry. From groundbreaking diagnostic technologies to advanced therapies and market opportunities, this video delves into how the landscape of lung cancer care is rapidly evolving. Learn about new treatment options, key players in the industry, and...
Asthma—a chronic inflammatory disease impacting over 350 million people worldwide—limits lives with symptoms like wheezing, shortness of breath, and chest tightness. Whether it’s allergic, exercise-induced, or nocturnal asthma, each type requires a unique approach for effective management. Fortunately, the biotech sector is bringing incredible advancements in managing asthma. From biologic therapies like Dupilumab and Tezepelumab...
Wegener’s Granulomatosis, now commonly known as Granulomatosis with Polyangiitis (GPA), is a rare autoimmune disease affecting the blood vessels. In this video, we explore the latest advances in diagnosis, treatment, and research for Wegener’s Granulomatosis. We’ll dive into the new medications, biologics, and therapies that are improving patient outcomes, as well as the innovative research...